Nature Communications (Dec 2020)

A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

  • Yfat Yahalom-Ronen,
  • Hadas Tamir,
  • Sharon Melamed,
  • Boaz Politi,
  • Ohad Shifman,
  • Hagit Achdout,
  • Einat B. Vitner,
  • Ofir Israeli,
  • Elad Milrot,
  • Dana Stein,
  • Inbar Cohen-Gihon,
  • Shlomi Lazar,
  • Hila Gutman,
  • Itai Glinert,
  • Lilach Cherry,
  • Yaron Vagima,
  • Shirley Lazar,
  • Shay Weiss,
  • Amir Ben-Shmuel,
  • Roy Avraham,
  • Reut Puni,
  • Edith Lupu,
  • Elad Bar-David,
  • Assa Sittner,
  • Noam Erez,
  • Ran Zichel,
  • Emanuelle Mamroud,
  • Ohad Mazor,
  • Haim Levy,
  • Orly Laskar,
  • Shmuel Yitzhaki,
  • Shmuel C. Shapira,
  • Anat Zvi,
  • Adi Beth-Din,
  • Nir Paran,
  • Tomer Israely

DOI
https://doi.org/10.1038/s41467-020-20228-7
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 13

Abstract

Read online

Here, the authors generate a replication-competent VSV based vaccine expressing SARS-CoV-2 spike protein and show protection in the hamster model with one dose. Analysis of the antibody response in mice shows induction of neutralizing antibodies and suggests a desirable Th1-biased response to the vaccine.